BLOOD BILIRUBIN UNCONJUGATED DECREASED

BLOOD BILIRUBIN UNCONJUGATED DECREASED was reported 36 times

These drug classes are most commonly taken by patients reporting BLOOD BILIRUBIN UNCONJUGATED DECREASED:

# Drug Count
0 Aromatase Inhibitor [EPC] 8
1 Nonsteroidal Anti-inflammatory Drug [EPC] 8
2 Proton Pump Inhibitor [EPC] 6
3 Aldosterone Antagonist [EPC] 4
4 Kinase Inhibitor [EPC] 4
5 Loop Diuretic [EPC] 4
6 Serotonin Reuptake Inhibitor [EPC] 4
7 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 4
8 Xanthine Oxidase Inhibitor [EPC] 4
9 CD52-directed Cytolytic Antibody [EPC] 3
10 Vitamin B12 [EPC] 3
11 Benzodiazepine [EPC] 2
12 Corticosteroid [EPC] 2
13 Interleukin-17A Antagonist [EPC] 2
14 Tetracycline-class Drug [EPC] 2
15 Vitamin C [EPC] 2
16 Vitamin D [EPC] 2
17 Angiotensin 2 Receptor Blocker [EPC] 1
18 Antidote [EPC] 1
19 Antidote for Acetaminophen Overdose [EPC] 1
20 Antimycobacterial [EPC] 1
21 Atypical Antipsychotic [EPC] 1
22 CD20-directed Cytolytic Antibody [EPC] 1
23 Calcium [EPC] 1
24 Catecholamine [EPC] 1
25 Estrogen Receptor Antagonist [EPC] 1
26 Factor Xa Inhibitor [EPC] 1
27 HMG-CoA Reductase Inhibitor [EPC] 1
28 Histamine-2 Receptor Antagonist [EPC] 1
29 Interleukin-6 Receptor Antagonist [EPC] 1
30 Mucolytic [EPC] 1
31 Osmotic Laxative [EPC] 1
32 Platelet Aggregation Inhibitor [EPC] 1
33 Potassium Channel Blocker [EPC] 1
34 Programmed Death Receptor-1 Blocking Antibody [EPC] 1
35 Proteasome Inhibitor [EPC] 1
36 RANK Ligand Inhibitor [EPC] 1
37 Retinoid [EPC] 1
38 Thiazide Diuretic [EPC] 1
39 alpha-Adrenergic Agonist [EPC] 1
40 beta-Adrenergic Agonist [EPC] 1
41 beta-Adrenergic Blocker [EPC] 1
42 beta3-Adrenergic Agonist [EPC] 1
43 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1
44 mTOR Inhibitor Immunosuppressant [EPC] 1